← Browse by Condition
Medical Condition

perennial allergic rhinitis par

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06339008 Phase 3
Recruiting

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

Enrollment
450 pts
Location
United States, Belgi...
Sponsor
Eli Lilly and Company
View Trial →